7714

Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetesZealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes

Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes

April 24, 2025 01:00 ET  | Source: Zealand Pharma Press release – No. 6 / 2025 Zealand Pharma announces first…

4 weeks ago
Zealand Pharma to participate in the Jefferies London Healthcare ConferenceZealand Pharma to participate in the Jefferies London Healthcare Conference

Zealand Pharma to participate in the Jefferies London Healthcare Conference

Press Release – No. 11 / 2024 Zealand Pharma to participate in the Jefferies London Healthcare Conference Copenhagen, Denmark, November 13,…

6 months ago